Physician profile
Nathan Thomas Moore
NPI 1346575081
$9,852.02
in general payments reported to CMS, 2019-2025
21 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,968 · 2020: $219 · 2021: $4,327 · 2022: $1,749 · 2023: $512 · 2024: $936 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.88 |
| Travel and Lodging | $133.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,642.69 | 2019-2024 | Mako, Motionsense Digital Goniometer, Restoration |
| Intravu INC. | $3,625.00 | 2021 | |
| Depuy Synthes Sales INC. | $429.43 | 2019-2023 | Velys, Na |
| Pacira Therapeutics, INC. | $174.11 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $153.36 | 2021-2024 | Tricera Handpiece |
| Smith+Nephew, INC. | $140.10 | 2019-2025 | Trigen Intertan, Evos, Conquest Fn |
| Boston Scientific Corporation | $117.92 | 2019 | |
| Smoky Mountain Surgical LLC | $106.50 | 2024 | |
| Dynasplint Systems INC. | $86.83 | 2021 | |
| Bioventus LLC | $53.84 | 2022-2025 | Xcell, Durolane |
| Avanos Medical | $51.67 | 2023-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Arteriocyte Medical Systems, INC. | $51.23 | 2024-2025 | Magellan |
| Convatec INC. | $42.34 | 2023-2024 | |
| Kerecis Limited | $39.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Vericel Corporation | $36.77 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $26.26 | 2022 | |
| Molnlycke Health Care US, LLC | $20.40 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Abbott Laboratories | $17.02 | 2025 | Proclaim |
| Medical Device Business Services, INC. | $12.64 | 2021 | |
| Zyla Life Sciences, INC. | $12.57 | 2020 | |
| Osteomed LLC | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.